Fengate announces final close of US$1.1 billion flagship infrastructure fund above target

TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) — Fengate Asset Management ('Fengate') today announced the final close of its flagship closed-ended infrastructure fund, Fengate Infrastructure Fund IV ('Fund IV' or 'the Fund') at US$1.1 billion, exceeding its fundraising target. In 2024, Fengate raised US$200 million for Fund IV co-investment vehicles, US$550 million for eStruxture Data Centers […]

ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer

(NASDAQ:ALXO), Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor response and a well-tolerated safety profile in a prospective randomized trial Greatest benefit observed among patients with confirmed HER2-positive cancer, as demonstrated by either fresh biopsy or ctDNA HER2-expression, with confirmed ORR of 48.9%

NOVAGOLD Files Year-End 2024 Report with Strong Treasury to Fund Key Activities for Long-Term Value Creation

(TSX:NG),(NYSE MKT:NG), VANCOUVER, British Columbia, Jan. 23, 2025 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) today filed its 2024 fiscal year-end report and provided an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”). Details of the financial

Shepherd Ave Capital Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on January 27, 2025

(NasdaqGM:SPHAU), Wilmington, DE, Jan. 23, 2025 (GLOBE NEWSWIRE) — Shepherd Ave Capital Acquisition Corporation (the “Company”) (Nasdaq: SPHAU), a blank check company, today announced that, commencing on January 27, 2025, holders of the 8,625,000 units (the “Units”) sold in the Company's initial public offering (the “Offering”) including Units sold upon the full exercise of the

Summit Ridge Energy Partners with OSF HealthCare to Deliver $9 Million in Energy Savings

Arlington, VA, Jan. 23, 2025 (GLOBE NEWSWIRE) — Summit Ridge Energy (SRE), the nation's leading commercial solar company, today announced a long-term agreement with OSF HealthCare, a not-for-profit healthcare network based in Illinois. Through this agreement, OSF HealthCare's network of over 180 hospitals and healthcare facilities will subscribe to 14 community solar projects owned and

Basetwo Raises $11.5M Series A to Transform Chemical Manufacturing with Physics AI Platform

TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) — Basetwo, an AI platform for manufacturing engineers, today announced it has raised USD $11.5M in Series A funding led by AVP with participation from existing investor Glasswing Ventures, Deloitte Ventures, Global Brain Ventures, Shimadzu Corporation, Chiyoda Corporation, and prominent UAE angel investors via Qora71. The investment allows the

United Sports Brands Appoints Kyle Schlegel as Senior Vice President of Marketing

Fountain Valley, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) — United Sports Brands is pleased to announce the appointment of Kyle Schlegel as Senior Vice President of Marketing. Kyle most recently served as the VP of Marketing & DTC of Weber, LLC, and has also held senior marketing leadership roles at top sports and consumer brands

Enphase Energy Announces U.S.-Produced IQ8 Microinverter Compliance with Build America, Buy America (BABA) Act

(NasdaqGM:ENPH), FREMONT, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that its IQ8(TM) Microinverters for residential and commercial applications, specifically the IQ8HC-72-M-DOM-US and IQ8P-3P-72-E-DOM-US SKUs, are now in compliance with the Build America,

Florida Oncology and Hematology and American Oncology Network Welcome Dr. Michele Ramirez

(Other OTC:AONC),(OTC US:AONC), NAPLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) — Community oncology practice Florida Oncology and Hematology (FOH), a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified medical oncologist and hematologist Michele Ramirez, MD, to its physician care team. Dr. Ramirez is now accepting patients at Naples Community Hospital (NCH)

Scroll to Top